ID
43789
Beschrijving
An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications; ODM derived from: https://clinicaltrials.gov/show/NCT02082249
Link
https://clinicaltrials.gov/show/NCT02082249
Trefwoorden
Versies (2)
- 01-05-16 01-05-16 -
- 20-09-21 20-09-21 -
Geüploaded op
20 september 2021
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Advanced Parkinson's Disease NCT02082249
Eligibility Advanced Parkinson's Disease NCT02082249
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
subject is enrolled in another clinical trial
Datatype
boolean
Alias
- UMLS CUI [1]
- C2348568
Beschrijving
interfere with patient
Datatype
boolean
Alias
- UMLS CUI [1]
- C0525058
- UMLS CUI [2]
- C0525058
- UMLS CUI [3]
- C0004936
Beschrijving
contraindication to continued levodopa therapy
Datatype
boolean
Alias
- UMLS CUI [1]
- C1301624
- UMLS CUI [2]
- C0023570
Beschrijving
Patient Non-Compliance
Datatype
boolean
Alias
- UMLS CUI [1]
- C0376405
Beschrijving
suicidal ideation
Datatype
boolean
Alias
- UMLS CUI [1]
- C0424000
Beschrijving
unsuitable candidate to continue to receive
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C3839545
- UMLS CUI [1,2]
- C2002915
Similar models
Eligibility Advanced Parkinson's Disease NCT02082249
- StudyEvent: Eligibility
C0525058 (UMLS CUI [2])
C0004936 (UMLS CUI [3])
C0023570 (UMLS CUI [2])
C2002915 (UMLS CUI [1,2])